Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Tax-Provision" stands at 2.77 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Merck & Company Inc's third quarter result of 0.958 Billion USD for the item "Tax Provision" represents an increase of 67.78 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 0.958 Billion USD for the item "Tax Provision" represents an increase of 3.12 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 2.77 Billion USD for the item "Tax Provision" represents an increase of 1.06 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 78.10 percent compared to the value the year prior.
The 1 year change in percent is 78.10.
The 3 year change in percent is 84.01.
The 5 year change in percent is 36.00.
The 10 year change in percent is -50.41.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Tax Provision | 905,699,262,464.00 |
![]() | Johnson & Johnson - Tax Provision | 486,508,953,600.00 |
![]() | AbbVie Inc - Tax Provision | 399,570,305,024.00 |
![]() | Roche Holding AG - Tax Provision | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Tax Provision | 280,205,508,085.11 |